Arvinas Inc Earnings

The next earnings date for Arvinas Inc is July 28, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of Arvinas Inc Earnings

Report DateEstimated Earnings Per Share
11/11/2025$-0.83
07/28/2025$-0.94

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Arvinas Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/01/2025Before Market$1.14217.56%
02/25/2025Before Market$-0.6334.29%
10/30/2024Before Market$-0.6829.17%
07/30/2024Before Market$-0.4943.02%
05/07/2024Before Market$-0.9731.69%
02/27/2024Before Market$-2.53-99.21%
11/07/2023Before Market$-1.1825.32%
08/08/2023Before Market$-1.2524.24%
05/05/2023Before Market$-1.54-1.99%
02/23/2023Before Market$-1.56-27.87%
11/08/2022Before Market$-1.24-9.73%
08/04/2022Before Market$-1.32-26.92%
05/05/2022Before Market$-1.20-34.83%
02/28/2022Before Market$-1-26.58%
11/03/2021Before Market$-0.94-140.87%
08/05/2021Before Market$-1.03-19.77%
05/04/2021Before Market$-0.84-2.44%
03/01/2021Before Market$-0.99-26.92%
11/05/2020Before Market$-0.79-16.18%
08/04/2020Before Market$-0.65-10.17%
04/28/2020Before Market$-0.566.67%
03/16/2020Before Market$-0.560.00%
11/04/2019After Market$0.21145.65%
08/05/2019Before Market$-0.55-37.50%
05/08/2019Before Market$-0.460.00%
03/26/2019Before Market$-0.5214.75%
11/14/2018After Market$-6.66-346.98%
09/27/2018After Market$-0.21---
06/22/2018---$-0.92---

More About Arvinas Inc

Website
https://www.arvinas.com
Country
USA
Full Time Employees
430

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.

“Arvinas Inc Earnings” Can Refer to the Arvinas Inc Earnings Date

Some people say “Arvinas Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Arvinas Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Arvinas Inc Stock on the Earnings Date

If you own Arvinas Inc stock (ARVN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Arvinas Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Arvinas Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Arvinas Inc Earnings

You can contact us any time if you would like to ask questions about Arvinas Inc earnings or anything else related to the stock market.